Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (1052)	12/16/1997 10:18:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

Are you saying that Schering AG (Germany) and Schering-Plough are not connected in any way? BTW, companies like Schering, Merk, Lily, etc. get involved with dozens of development stage firms every year. These firms usually have no other source of revenue except some upfront cash and hopes of milestone/royalty payments (just like Zonagen). Many of these firms end up bankrupt. BTW - if you want to take a look into the future of Zonagen, check out the VVUS stock performance over the past few weeks. The bottom line is that stock touts and hypesters have latched on to the ED market as the "next big thing". Unfortunately, they have vastly overestimated its size, and they have pinned their hopes on losers like Vivus and frauds like Zonagen. Here's some good advice. Go to Vegas, buy yourself some gifts, take a vacation, etc. But don't be a sucker and invest in scams like this company. They are only geared to do one thing - to separate victims from their money.